-
Speaking Engagement
Unintended Consequences: Understanding the Fallout of the IRA on Government Payor Programs and the Private Sector
ACI 22nd Annual Rx Drug Pricing Boot Camp -
Blog Post
Biden Administration Prioritizing Domestic Production of Pharmaceuticals . . . Again?
Government Contracts Navigator -
Speaking Engagement
ACI Rx Drug Pricing & Rebate Fundamentals
ACI Virtual Proficiency Series -
Media Coverage
FCA Suits Anticipated as COVID Criminal Cases Wrap Up
Law360 -
Blog Post
Government Offerors—There Are No Foolish Questions
Government Contracts Navigator -
Blog Post
Conflicting State and Federal Requirements for Government Contractors . . . Again
Government Contracts Navigator -
Blog Post
CMS Proposing Major Changes to Medicaid Drug Rebate Program
Government Contracts Navigator -
Blog Post
Federal Contractor Vaccine Mandate to End
Government Contracts Navigator -
Speaking Engagement
Best Practices for FSS Post Award Compliance and Audit Preparation
17th Annual ACI “BIG FOUR” Pharmaceutical Pricing Boot Camp -
Speaking Engagement
Understanding Fraud and Abuse Control as Affected by New Provisions under Government Drug Payor Programs
ACI 21st Annual Rx Drug Pricing Boot Camp